SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
SEC Accession No. 0001493152-23-017301
Filing Date
2023-05-15
Accepted
2023-05-15 16:05:33
Documents
1
Period of Report
2023-03-31
Effectiveness Date
2023-05-15

Document Format Files

Seq Description Document Type Size
1 formnt10-q.htm NT 10-Q 34241
  Complete submission text file 0001493152-23-017301.txt   35401
Mailing Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452
Business Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452 (201) 444-4947
RespireRx Pharmaceuticals Inc. (Filer) CIK: 0000849636 (see all company filings)

IRS No.: 330303583 | State of Incorp.: DE | Fiscal Year End: 1231
Type: NT 10-Q | Act: 34 | File No.: 001-16467 | Film No.: 23922012
SIC: 2834 Pharmaceutical Preparations